社论:食品中的乳化剂和增稠剂会改变肠道渗透性吗?

IF 6.6 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Alimentary Pharmacology & Therapeutics Pub Date : 2024-09-09 DOI:10.1111/apt.18222
Joshua Reid, Robin Spiller
{"title":"社论:食品中的乳化剂和增稠剂会改变肠道渗透性吗?","authors":"Joshua Reid,&nbsp;Robin Spiller","doi":"10.1111/apt.18222","DOIUrl":null,"url":null,"abstract":"<p>Changing from a traditional home-cooked diet to a ‘Western diet’, high in ultra-processed foods (UPFs), may play a role in the recent increase in Crohn's disease observed in many countries where it was previously rare.<span><sup>1, 2</sup></span> Fitzpatrick et al hypothesised that diets high in UPFs increase gut permeability, allowing access of pro-inflammatory bacterial products such as lipopolysaccharide (LPS) to the immune system leading to IBD.<span><sup>3</sup></span> Studying this involved creating a high emulsifier diet (HED) and a low emulsifier diet (LED), with 70% and 29% calories from UPFs, respectively.<span><sup>4</sup></span> They identified 30 different emulsifiers and thickeners in the HED, which have very varied chemical structures and properties with the common aim of preventing phase separation. For example, surfactant-type emulsifiers (e.g. soy lecithin) lower surface tension, whereas biopolymer-type thickeners (e.g. pectin) increase viscosity.<span><sup>5</sup></span> The dominant thickener in the HED was acetylated distarch adipate (E1422), accounting for 60% (1614/2815 mg/day) of total emulsifier/thickener content. Acetylated starch is a resistant starch, which increases colonic short-chain fatty acids although extensive human feeding studies do not show any deleterious effect.<span><sup>6</sup></span> By contrast, the emulsifier polysorbate 80 was present in minute amounts (0.00002 mg/day) with other additives in the range 5–100 mg/day each.</p><p>The HED and LED diets were fed in a randomised single-blinded, cross-over study to assess the effect on the upper small bowel permeability as assessed by the lactulose/rhamnose ratio (LRR)<span><sup>7</sup></span> and blood levels of LPS. The results were somewhat surprising in that the HED actually decreased the LRR and LPS. However, when stressed, those on the HED had a rise in LRR while those on the LED had a fall. Unfortunately, there was an order-effect meaning this stress-induced increase in LRR on the HED was only observed if HED was consumed first. While the authors should be congratulated on tackling an important question, the results raise more questions than answers. The HED initially appeared to decrease LRR; was this due to a response to injury incurred on starting the HED, or does it reflect adherence of fibres consumed the night before to the mucus layer impeding paracellular uptake of a large molecule like lactulose?</p><p>Pre-clinical studies using IBD models such as that of Ogulur et al.<span><sup>8</sup></span> have tended to focus on somewhat atypical emulsifiers, which are actually consumed in very small amounts. What this study teaches us is that future studies should test substances that predominate in UPFs and have a specific mechanism, for example emulsifiers such as lecithins<span><sup>9, 10</sup></span> or thickeners such as modified starch. Human studies should avoid a cross-over design and be less ambitious, using just one agent, such as acetylated starch or soy lecithin as an intervention. Such a study is more likely to obtain a clear answer as to whether specific emulsifiers or thickeners do significantly alter human gut permeability when taken as part of a normal diet, something that is at present unclear.</p><p><b>Joshua Reid:</b> Conceptualization; writing – review and editing. <b>Robin Spiller:</b> Conceptualization; writing – review and editing.</p><p>Supported by NIHR Nottingham BRC (NIHR203310).</p><p>JR declares no conflicts of interest. RS has recieved research grants from Sanofi and Nestle and is consultant to Enterobiotix.</p><p>This article is linked to Fitzpatrick et al papers. To view these articles, visit https://doi.org/10.1111/apt.18172 and https://doi.org/10.1111/apt.18266</p>","PeriodicalId":121,"journal":{"name":"Alimentary Pharmacology & Therapeutics","volume":null,"pages":null},"PeriodicalIF":6.6000,"publicationDate":"2024-09-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/apt.18222","citationCount":"0","resultStr":"{\"title\":\"Editorial: Emulsifiers and thickeners in our food—Do they alter gut permeability?\",\"authors\":\"Joshua Reid,&nbsp;Robin Spiller\",\"doi\":\"10.1111/apt.18222\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Changing from a traditional home-cooked diet to a ‘Western diet’, high in ultra-processed foods (UPFs), may play a role in the recent increase in Crohn's disease observed in many countries where it was previously rare.<span><sup>1, 2</sup></span> Fitzpatrick et al hypothesised that diets high in UPFs increase gut permeability, allowing access of pro-inflammatory bacterial products such as lipopolysaccharide (LPS) to the immune system leading to IBD.<span><sup>3</sup></span> Studying this involved creating a high emulsifier diet (HED) and a low emulsifier diet (LED), with 70% and 29% calories from UPFs, respectively.<span><sup>4</sup></span> They identified 30 different emulsifiers and thickeners in the HED, which have very varied chemical structures and properties with the common aim of preventing phase separation. For example, surfactant-type emulsifiers (e.g. soy lecithin) lower surface tension, whereas biopolymer-type thickeners (e.g. pectin) increase viscosity.<span><sup>5</sup></span> The dominant thickener in the HED was acetylated distarch adipate (E1422), accounting for 60% (1614/2815 mg/day) of total emulsifier/thickener content. Acetylated starch is a resistant starch, which increases colonic short-chain fatty acids although extensive human feeding studies do not show any deleterious effect.<span><sup>6</sup></span> By contrast, the emulsifier polysorbate 80 was present in minute amounts (0.00002 mg/day) with other additives in the range 5–100 mg/day each.</p><p>The HED and LED diets were fed in a randomised single-blinded, cross-over study to assess the effect on the upper small bowel permeability as assessed by the lactulose/rhamnose ratio (LRR)<span><sup>7</sup></span> and blood levels of LPS. The results were somewhat surprising in that the HED actually decreased the LRR and LPS. However, when stressed, those on the HED had a rise in LRR while those on the LED had a fall. Unfortunately, there was an order-effect meaning this stress-induced increase in LRR on the HED was only observed if HED was consumed first. While the authors should be congratulated on tackling an important question, the results raise more questions than answers. The HED initially appeared to decrease LRR; was this due to a response to injury incurred on starting the HED, or does it reflect adherence of fibres consumed the night before to the mucus layer impeding paracellular uptake of a large molecule like lactulose?</p><p>Pre-clinical studies using IBD models such as that of Ogulur et al.<span><sup>8</sup></span> have tended to focus on somewhat atypical emulsifiers, which are actually consumed in very small amounts. What this study teaches us is that future studies should test substances that predominate in UPFs and have a specific mechanism, for example emulsifiers such as lecithins<span><sup>9, 10</sup></span> or thickeners such as modified starch. Human studies should avoid a cross-over design and be less ambitious, using just one agent, such as acetylated starch or soy lecithin as an intervention. Such a study is more likely to obtain a clear answer as to whether specific emulsifiers or thickeners do significantly alter human gut permeability when taken as part of a normal diet, something that is at present unclear.</p><p><b>Joshua Reid:</b> Conceptualization; writing – review and editing. <b>Robin Spiller:</b> Conceptualization; writing – review and editing.</p><p>Supported by NIHR Nottingham BRC (NIHR203310).</p><p>JR declares no conflicts of interest. RS has recieved research grants from Sanofi and Nestle and is consultant to Enterobiotix.</p><p>This article is linked to Fitzpatrick et al papers. To view these articles, visit https://doi.org/10.1111/apt.18172 and https://doi.org/10.1111/apt.18266</p>\",\"PeriodicalId\":121,\"journal\":{\"name\":\"Alimentary Pharmacology & Therapeutics\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":6.6000,\"publicationDate\":\"2024-09-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1111/apt.18222\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Alimentary Pharmacology & Therapeutics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/apt.18222\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alimentary Pharmacology & Therapeutics","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/apt.18222","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

1,2菲茨帕特里克(Fitzpatrick)等人推测,高乳化剂饮食会增加肠道渗透性,使脂多糖(LPS)等促炎性细菌产物进入免疫系统,导致肠道疾病。他们在高乳化剂膳食(HED)和低乳化剂膳食(LED)中发现了 30 种不同的乳化剂和增稠剂,这些乳化剂和增稠剂的化学结构和性质各不相同,其共同目的是防止相分离。例如,表面活性剂型乳化剂(如大豆卵磷脂)可降低表面张力,而生物聚合物型增稠剂(如果胶)可增加粘度。5 HED 中最主要的增稠剂是乙酰化己二酸二淀粉(E1422),占乳化剂/增稠剂总含量的 60%(1614/2815 毫克/天)。乙酰化淀粉是一种抗性淀粉,会增加结肠短链脂肪酸,尽管大量人体喂养研究并未显示出任何有害影响。相比之下,乳化剂聚山梨醇酯 80 的用量很小(0.00002 毫克/天),其他添加剂的用量在 5-100 毫克/天之间。HED 日粮和 LED 日粮进行了随机单盲交叉研究,以评估通过乳糖/鼠李糖比率(LRR)7 和血液中 LPS 水平评估的对上小肠通透性的影响。结果有些出人意料,因为 HED 实际上降低了 LRR 和 LPS。然而,当受到压力时,服用 HED 的人 LRR 上升,而服用 LED 的人 LRR 下降。不幸的是,存在一种顺序效应,即只有首先消耗 HED 的情况下,才能观察到 HED 的 LRR 因压力而增加。虽然应该祝贺作者解决了一个重要的问题,但结果提出的问题多于答案。HED最初似乎降低了LRR;这是由于对开始摄入HED时所受伤害的反应,还是反映了前一天晚上摄入的纤维粘附在粘液层上,阻碍了像乳糖这样的大分子的旁细胞摄入?这项研究给我们的启示是,未来的研究应测试在 UPF 中占主导地位并具有特定机制的物质,例如卵磷脂9、10 等乳化剂或变性淀粉等增稠剂。人体研究应避免采用交叉研究的设计,而应降低要求,只使用一种制剂,如乙酰化淀粉或大豆卵磷脂作为干预措施。这样的研究更有可能就特定乳化剂或增稠剂在作为正常饮食的一部分时是否会显著改变人体肠道渗透性得出明确的答案,而这一点目前还不清楚:构思;写作--审阅和编辑。罗宾-斯皮勒JR声明没有利益冲突。RS获得了赛诺菲和雀巢公司的研究资助,并且是Enterobiotix公司的顾问。要查看这些文章,请访问 https://doi.org/10.1111/apt.18172 和 https://doi.org/10.1111/apt.18266。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Editorial: Emulsifiers and thickeners in our food—Do they alter gut permeability?

Changing from a traditional home-cooked diet to a ‘Western diet’, high in ultra-processed foods (UPFs), may play a role in the recent increase in Crohn's disease observed in many countries where it was previously rare.1, 2 Fitzpatrick et al hypothesised that diets high in UPFs increase gut permeability, allowing access of pro-inflammatory bacterial products such as lipopolysaccharide (LPS) to the immune system leading to IBD.3 Studying this involved creating a high emulsifier diet (HED) and a low emulsifier diet (LED), with 70% and 29% calories from UPFs, respectively.4 They identified 30 different emulsifiers and thickeners in the HED, which have very varied chemical structures and properties with the common aim of preventing phase separation. For example, surfactant-type emulsifiers (e.g. soy lecithin) lower surface tension, whereas biopolymer-type thickeners (e.g. pectin) increase viscosity.5 The dominant thickener in the HED was acetylated distarch adipate (E1422), accounting for 60% (1614/2815 mg/day) of total emulsifier/thickener content. Acetylated starch is a resistant starch, which increases colonic short-chain fatty acids although extensive human feeding studies do not show any deleterious effect.6 By contrast, the emulsifier polysorbate 80 was present in minute amounts (0.00002 mg/day) with other additives in the range 5–100 mg/day each.

The HED and LED diets were fed in a randomised single-blinded, cross-over study to assess the effect on the upper small bowel permeability as assessed by the lactulose/rhamnose ratio (LRR)7 and blood levels of LPS. The results were somewhat surprising in that the HED actually decreased the LRR and LPS. However, when stressed, those on the HED had a rise in LRR while those on the LED had a fall. Unfortunately, there was an order-effect meaning this stress-induced increase in LRR on the HED was only observed if HED was consumed first. While the authors should be congratulated on tackling an important question, the results raise more questions than answers. The HED initially appeared to decrease LRR; was this due to a response to injury incurred on starting the HED, or does it reflect adherence of fibres consumed the night before to the mucus layer impeding paracellular uptake of a large molecule like lactulose?

Pre-clinical studies using IBD models such as that of Ogulur et al.8 have tended to focus on somewhat atypical emulsifiers, which are actually consumed in very small amounts. What this study teaches us is that future studies should test substances that predominate in UPFs and have a specific mechanism, for example emulsifiers such as lecithins9, 10 or thickeners such as modified starch. Human studies should avoid a cross-over design and be less ambitious, using just one agent, such as acetylated starch or soy lecithin as an intervention. Such a study is more likely to obtain a clear answer as to whether specific emulsifiers or thickeners do significantly alter human gut permeability when taken as part of a normal diet, something that is at present unclear.

Joshua Reid: Conceptualization; writing – review and editing. Robin Spiller: Conceptualization; writing – review and editing.

Supported by NIHR Nottingham BRC (NIHR203310).

JR declares no conflicts of interest. RS has recieved research grants from Sanofi and Nestle and is consultant to Enterobiotix.

This article is linked to Fitzpatrick et al papers. To view these articles, visit https://doi.org/10.1111/apt.18172 and https://doi.org/10.1111/apt.18266

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
15.60
自引率
7.90%
发文量
527
审稿时长
3-6 weeks
期刊介绍: Alimentary Pharmacology & Therapeutics is a global pharmacology journal focused on the impact of drugs on the human gastrointestinal and hepato-biliary systems. It covers a diverse range of topics, often with immediate clinical relevance to its readership.
期刊最新文献
Editorial: The Impact of Socioeconomic and Ethnic Factors on Chronic Liver Disease Letter: Enhancing Predictive Models for Paediatric Ulcerative Colitis—Addressing Socioeconomic, Environmental and Clinical Factors. Authors' Reply Letter: Enhancing Predictive Models for Paediatric Ulcerative Colitis—Addressing Socioeconomic, Environmental and Clinical Factors Faecal Volatile Organic Compounds to Detect Colorectal Neoplasia in Lynch Syndrome—A Prospective Longitudinal Multicentre Study Editorial: Enhancing targeted screening of people living with HIV for liver fibrosis
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1